Helixmith Co., Ltd (KOSDAQ:084990)
5,920.00
+10.00 (0.17%)
Jan 19, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 272.6 billion as of January 16, 2026. Its market cap has increased by 113.72% in one year.
Market Cap
272.60B
Enterprise Value
190.28B
Revenue
3.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,920.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 272.60B, an increase of 14.23%. That is a compound annual growth rate of 0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 272.60B | -4.82% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 90.13T |
| Celltrion | 45.73T |
| ALTEOGEN | 27.70T |
| ABL Bio | 10.89T |
| SK Biopharmaceuticals | 9.43T |
| Yuhan | 8.05T |
| HLB Co., Ltd. | 6.97T |
| Sam Chun Dang Pharm. | 6.49T |